Lista de obras - James B Dale - Dominio Público Uruguay

A 28-kilodalton fibronectin-binding protein of group a streptococci

artículo científico publicado en 1992

A novel live vector group A streptococcal emm type 9 vaccine delivered intranasally protects mice against challenge infection with emm type 9 group A streptococci

artículo científico publicado en 2014

A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development

artículo científico publicado en 2014

Added value of the emm-cluster typing system to analyze group A Streptococcus epidemiology in high-income settings.

artículo científico publicado en 2014

Age-associated differences in prevalence of group A streptococcal type-specific M antibodies in children.

artículo científico publicado en 2008

Comparison of the leader sequences of four group A streptococcal M protein genes.

artículo científico publicado en 1988

Current status of group A streptococcal vaccine development.

artículo científico publicado en 2008

Group A Streptococcal Pharyngitis Serotype Surveillance in North America, 2000–2002

article

Group A streptococcal emm type prevalence among symptomatic children in Cape Town and potential vaccine coverage

scientific article published on February 2014

Group A streptococcal vaccines: paving a path for accelerated development

artículo científico publicado en 2013

Group A streptococcus expresses a trio of surface proteins containing protective epitopes

artículo científico publicado en 2014

Identification of a gene within a pathogenicity island of enterotoxigenic Escherichia coli H10407 required for maximal secretion of the heat-labile enterotoxin.

artículo científico publicado en 2000

Immune Cross-Opsonization Within emm Clusters Following Group A Streptococcus Skin Infection: Broadening the Scope of Type-Specific Immunity.

artículo científico publicado en 2017

Immunogenicity of a 26-valent group A streptococcal vaccine.

artículo científico publicado en 2002

In memoriam: Gene H. Stollerman.

artículo científico publicado en 2014

Inactivation of DltA modulates virulence factor expression in Streptococcus pyogenes

artículo científico publicado en 2009

Intranasal Immunization with Recombinant Group A Streptococcal M Protein Fragment Fused to the B Subunit of Escherichia coli Labile Toxin Protects Mice against Systemic Challenge Infections

artículo científico publicado en 1995

Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections.

artículo científico publicado en 2004

Lipoteichoic acid and M protein: dual adhesins of group A streptococci

artículo científico publicado en 1992

Mapping the Fibrinogen-Binding Domain of Serum Opacity Factor of Group A Streptococci

artículo científico publicado en 2002

Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments

artículo científico publicado en 1999

Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes

artículo científico publicado en 2005

New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci ⬇️

artículo científico publicado el 13 de septiembre de 2011

One More Disguise in the Stealth Behavior of Streptococcus pyogenes.

artículo científico publicado en 2016

Passive Protection of Mice against Group A Streptococcal Pharyngeal Infection by Lipoteichoic Acid

artículo científico publicado en 1994

Potential coverage of a multivalent M protein-based group A streptococcal vaccine ⬇️

artículo científico publicado el 31 de enero de 2013

Prevalence of rheumatic heart disease in children and young adults in Nicaragua

artículo científico publicado en 2010

Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections

artículo científico publicado en 2010

Progress toward a global group a streptococcal vaccine.

artículo científico publicado en 2013

Prospective Longitudinal Analysis of Immune Responses in Pediatric Subjects After Pharyngeal Acquisition of Group A Streptococci.

artículo científico publicado en 2017

Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshop.

artículo científico publicado en 2005

Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart ⬇️

artículo científico publicado el 1 de octubre de 1982

Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes.

artículo científico publicado en 2010

Protective immunogenicity and T lymphocyte specificity of a trivalent hybrid peptide containing NH2-terminal sequences of types 5, 6, and 24 M proteins synthesized in tandem

artículo científico publicado en 1987

Protective immunogenicity of group A streptococcal M-related proteins

artículo científico publicado en 2015

Rationale and design of the African group A streptococcal infection registry: the AFROStrep study

artículo científico publicado en 2016

Recombinant, octavalent group A streptococcal M protein vaccine

artículo científico publicado en 1996

Relationship between expression of the family of M proteins and lipoteichoic acid to hydrophobicity and biofilm formation in Streptococcus pyogenes

artículo científico publicado en 2009

Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers

artículo científico publicado en 2005

Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.

artículo científico publicado en 2003

Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates.

artículo científico publicado en 2009

Status of research and development of vaccines for Streptococcus pyogenes

artículo científico publicado en 2016

Streptococcal pharyngitis in schoolchildren in Bamako, Mali

artículo científico publicado en 2015

Streptococcal protective antigens (Spa): a new family of type-specific proteins of group A streptococci.

artículo científico publicado en 2009

Structure-based design of broadly protective group a streptococcal M protein-based vaccines

artículo científico publicado en 2016

Structure-based group A streptococcal vaccine design: Helical wheel homology predicts antibody cross-reactivity among streptococcal M protein-derived peptides

artículo científico publicado en 2020

The Cape Town Clinical Decision Rule for Streptococcal Pharyngitis in Children

artículo científico publicado en 2016

The NH(2)-terminal region of Streptococcus pyogenes M5 protein confers protection against degradation by proteases and enhances mucosal colonization of mice.

artículo científico publicado en 2010

The importance of the group a streptococcus capsule in the pathogenesis of human infections: a historical perspective.

artículo científico publicado en 2008

The reemergence of serious group A streptococcal infections and acute rheumatic fever.

artículo científico publicado en 1996

Trivalent M-related protein as a component of next generation group A streptococcal vaccines

artículo científico publicado en 2017

Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein.

artículo científico publicado en 1983

Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein

artículo científico publicado en 1981

Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection.

artículo científico publicado en 2014

Lista de obras de James B Dale

A 28-kilodalton fibronectin-binding protein of group a streptococci

A novel live vector group A streptococcal emm type 9 vaccine delivered intranasally protects mice against challenge infection with emm type 9 group A streptococci

A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development

Added value of the emm-cluster typing system to analyze group A Streptococcus epidemiology in high-income settings.

Age-associated differences in prevalence of group A streptococcal type-specific M antibodies in children.

Comparison of the leader sequences of four group A streptococcal M protein genes.

Current status of group A streptococcal vaccine development.

Group A Streptococcal Pharyngitis Serotype Surveillance in North America, 2000–2002

Group A streptococcal emm type prevalence among symptomatic children in Cape Town and potential vaccine coverage

Group A streptococcal vaccines: paving a path for accelerated development

Group A streptococcus expresses a trio of surface proteins containing protective epitopes

Identification of a gene within a pathogenicity island of enterotoxigenic Escherichia coli H10407 required for maximal secretion of the heat-labile enterotoxin.

Immune Cross-Opsonization Within emm Clusters Following Group A Streptococcus Skin Infection: Broadening the Scope of Type-Specific Immunity.

Immunogenicity of a 26-valent group A streptococcal vaccine.

In memoriam: Gene H. Stollerman.

Inactivation of DltA modulates virulence factor expression in Streptococcus pyogenes

Intranasal Immunization with Recombinant Group A Streptococcal M Protein Fragment Fused to the B Subunit of Escherichia coli Labile Toxin Protects Mice against Systemic Challenge Infections

Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections.

Lipoteichoic acid and M protein: dual adhesins of group A streptococci

Mapping the Fibrinogen-Binding Domain of Serum Opacity Factor of Group A Streptococci

Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments

Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes

New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci ⬇️

One More Disguise in the Stealth Behavior of Streptococcus pyogenes.

Passive Protection of Mice against Group A Streptococcal Pharyngeal Infection by Lipoteichoic Acid

Potential coverage of a multivalent M protein-based group A streptococcal vaccine ⬇️

Prevalence of rheumatic heart disease in children and young adults in Nicaragua

Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections

Progress toward a global group a streptococcal vaccine.

Prospective Longitudinal Analysis of Immune Responses in Pediatric Subjects After Pharyngeal Acquisition of Group A Streptococci.

Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshop.

Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart ⬇️

Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes.

Protective immunogenicity and T lymphocyte specificity of a trivalent hybrid peptide containing NH2-terminal sequences of types 5, 6, and 24 M proteins synthesized in tandem

Protective immunogenicity of group A streptococcal M-related proteins

Rationale and design of the African group A streptococcal infection registry: the AFROStrep study

Recombinant, octavalent group A streptococcal M protein vaccine

Relationship between expression of the family of M proteins and lipoteichoic acid to hydrophobicity and biofilm formation in Streptococcus pyogenes

Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers

Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.

Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates.

Status of research and development of vaccines for Streptococcus pyogenes

Streptococcal pharyngitis in schoolchildren in Bamako, Mali

Streptococcal protective antigens (Spa): a new family of type-specific proteins of group A streptococci.

Structure-based design of broadly protective group a streptococcal M protein-based vaccines

Structure-based group A streptococcal vaccine design: Helical wheel homology predicts antibody cross-reactivity among streptococcal M protein-derived peptides

The Cape Town Clinical Decision Rule for Streptococcal Pharyngitis in Children

The NH(2)-terminal region of Streptococcus pyogenes M5 protein confers protection against degradation by proteases and enhances mucosal colonization of mice.

The importance of the group a streptococcus capsule in the pathogenesis of human infections: a historical perspective.

The reemergence of serious group A streptococcal infections and acute rheumatic fever.

Trivalent M-related protein as a component of next generation group A streptococcal vaccines

Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein.

Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein

Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection.